Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine versus sufentanil for postoperative analgesia after UPPP
ChiCTR2600132706Phase 4Not yet recruiting
- Sponsor
- Linyi People's Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tegileridine in postoperative pain (2 arms), sponsored by Linyi People's Hospital. Primary endpoint: Area under the curve of visual analogue scale scores for dysphagia pain within 48 hours postoperatively. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600132706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132706.